A pragmatic randomised controlled trial of 'PhysioDirect' telephone assessment and advice services for patients with musculoskeletal problems: Economic evaluation

Sandra Hollinghurst*, Joanna Coast, John Busby, Annette Bishop, Nadine E. Foster, Angelo Franchini, Sean Grove, Jeanette Hall, Cherida Hopper, Surinder Kaur, Alan A. Montgomery, Chris Salisbury

*Corresponding author for this work

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives: To compare the cost-effectiveness of PhysioDirect with usual physiotherapy care for patients with musculoskeletal problems. Design: (1) Cost-consequences comparing cost to the National Health Service (NHS), to patients, and the value of lost productivity with a range of outcomes. (2) Cost-utility analysis comparing cost to the NHS with Quality-Adjusted Life Years (QALYs). Setting: Four physiotherapy services in England. Participants: Adults (18+) referred by their general practitioner or self-referred for physiotherapy. Interventions: PhysioDirect involved telephone assessment and advice followed by face-to-face care if needed. Usual care patients were placed on a waiting list for face-to-face care. Primary and secondary outcomes: Primary clinical outcome: physical component summary from the SF-36v2 at 6 months. Also included in the cost-consequences: Measure Yourself Medical Outcomes Profile; a Global Improvement Score; response to treatment; patient satisfaction; waiting time. Outcome for the cost-utility analysis: QALYs. Results: 2249 patients took part (1506 PhysioDirect; 743 usual care). (1) Cost-consequences: there was no evidence of a difference between the two groups in the cost of physiotherapy, other NHS services, personal costs or value of time off work. Outcomes were also similar. (2) Cost-utility analysis based on complete cases (n=1272). Total NHS costs, including the cost of physiotherapy were higher in the PhysioDirect group by £19.30 (95% CI -£37.60 to £76.19) and there was a QALY gain of 0.007 (95% CI -0.003 to 0.016). The incremental cost-effectiveness ratio was £2889 and the net monetary benefit at λ=£20 000 was £117 (95% CI -£86 to £310). Conclusions: PhysioDirect may be a cost-effective alternative to usual physiotherapy care, though only with careful management of staff time. Physiotherapists providing the service must be more fully occupied than was possible under trial conditions: consideration should be given to the scale of operation, opening.

Original languageEnglish
Article numbere003406
JournalBMJ Open
Volume3
Issue number10
DOIs
Publication statusPublished - 04 Nov 2013
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A pragmatic randomised controlled trial of 'PhysioDirect' telephone assessment and advice services for patients with musculoskeletal problems: Economic evaluation'. Together they form a unique fingerprint.

  • Cite this

    Hollinghurst, S., Coast, J., Busby, J., Bishop, A., Foster, N. E., Franchini, A., Grove, S., Hall, J., Hopper, C., Kaur, S., Montgomery, A. A., & Salisbury, C. (2013). A pragmatic randomised controlled trial of 'PhysioDirect' telephone assessment and advice services for patients with musculoskeletal problems: Economic evaluation. BMJ Open, 3(10), [e003406]. https://doi.org/10.1136/bmjopen-2013-003406